BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19180614)

  • 1. Evidence for a stereoelectronic effect in human oxygen sensing.
    Loenarz C; Mecinović J; Chowdhury R; McNeill LA; Flashman E; Schofield CJ
    Angew Chem Int Ed Engl; 2009; 48(10):1784-7. PubMed ID: 19180614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
    Chowdhury R; McDonough MA; Mecinović J; Loenarz C; Flashman E; Hewitson KS; Domene C; Schofield CJ
    Structure; 2009 Jul; 17(7):981-9. PubMed ID: 19604478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Hippel-Lindau β-domain-luciferase fusion protein as a bioluminescent hydroxyproline sensor for a hypoxia-inducible factor prolyl hydroxylase assay.
    Hong S; Yum S; Ha NC; Jung Y
    Anal Biochem; 2010 Dec; 407(2):220-5. PubMed ID: 20705044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical basis for the selectivity of the von Hippel Lindau tumor suppressor pVHL for prolyl-hydroxylated HIF-1alpha.
    Illingworth CJ; Loenarz C; Schofield CJ; Domene C
    Biochemistry; 2010 Aug; 49(32):6936-44. PubMed ID: 20695530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
    Jaakkola P; Mole DR; Tian YM; Wilson MI; Gielbert J; Gaskell SJ; von Kriegsheim A; Hebestreit HF; Mukherji M; Schofield CJ; Maxwell PH; Pugh CW; Ratcliffe PJ
    Science; 2001 Apr; 292(5516):468-72. PubMed ID: 11292861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
    Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
    EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.
    Foxler DE; Bridge KS; James V; Webb TM; Mee M; Wong SC; Feng Y; Constantin-Teodosiu D; Petursdottir TE; Bjornsson J; Ingvarsson S; Ratcliffe PJ; Longmore GD; Sharp TV
    Nat Cell Biol; 2012 Jan; 14(2):201-8. PubMed ID: 22286099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an alternative mechanism of degradation of the hypoxia-inducible factor-1alpha.
    André H; Pereira TS
    J Biol Chem; 2008 Oct; 283(43):29375-84. PubMed ID: 18694926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
    Flashman E; Davies SL; Yeoh KK; Schofield CJ
    Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proline hydroxylation and gene expression.
    Kaelin WG
    Annu Rev Biochem; 2005; 74():115-28. PubMed ID: 15952883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of gene expression by the hypoxia-inducible factors.
    Fedele AO; Whitelaw ML; Peet DJ
    Mol Interv; 2002 Jul; 2(4):229-43. PubMed ID: 14993394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
    Masson N; Ratcliffe PJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3041-9. PubMed ID: 12829734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the Binding Interaction between the Hypoxia-Inducible Transcription Factor and the von Hippel-Lindau Suppressor.
    Domene C; Jorgensen C; Vanommeslaeghe K; Schofield CJ; MacKerell A
    J Chem Theory Comput; 2015 Aug; 11(8):3946-54. PubMed ID: 26574473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death.
    Tennant DA; Frezza C; MacKenzie ED; Nguyen QD; Zheng L; Selak MA; Roberts DL; Dive C; Watson DG; Aboagye EO; Gottlieb E
    Oncogene; 2009 Nov; 28(45):4009-21. PubMed ID: 19718054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL).
    Heir P; Ohh M
    Methods Mol Biol; 2016; 1458():87-94. PubMed ID: 27581016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic HIF1A regulation during human placental development.
    Ietta F; Wu Y; Winter J; Xu J; Wang J; Post M; Caniggia I
    Biol Reprod; 2006 Jul; 75(1):112-21. PubMed ID: 16611863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases.
    Cho H; Park H; Yang EG
    Biochem Biophys Res Commun; 2005 Nov; 337(1):275-80. PubMed ID: 16182243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the intracellular localization of HIF-prolyl hydroxylases.
    Yasumoto K; Kowata Y; Yoshida A; Torii S; Sogawa K
    Biochim Biophys Acta; 2009 May; 1793(5):792-7. PubMed ID: 19339211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology.
    Dao JH; Kurzeja RJ; Morachis JM; Veith H; Lewis J; Yu V; Tegley CM; Tagari P
    Anal Biochem; 2009 Jan; 384(2):213-23. PubMed ID: 18952043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico investigation of PHD-3 specific HIF1-α proline 567 hydroxylation: a new player in the VHL/HIF-1α interaction pathway?
    Minervini G; Masiero A; Moro S; Tosatto SC
    FEBS Lett; 2013 Sep; 587(18):2996-3001. PubMed ID: 23886708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.